Hoertel et al. Biol Psychiatry Glob Open Sci. 2022


 

Risk of death in individuals hospitalized for COVID-19 with and without psychiatric disorders: an observational multicenter study in France.  Hoertel N, Sánchez-Rico M, Muela P, Abellán M, Blanco C, Leboyer M, Cougoule C, Gulbins E, Kornhuber J, Carpinteiro A, Becker KA, Vernet R, Beeker N, Neuraz A, Alvarado JM, Herrera-Morueco JJ, Airagnes G, Lemogne C, Limosin F.Biol Psychiatry Glob Open Sci. 2022 Jan 4;. doi: 10.1016/j.bpsgos.2021.12.007. [Epub ahead of print] PubMed PMID: 35013734; PubMed Central PMCID: PMC8730644. OPEN ACCES. Download from HAL-INSERM

 

Background: Prior research suggests that psychiatric disorders could be linked to increased mortality among patients with COVID-19. However, whether all or specific psychiatric disorders are intrinsic risk factors of death in COVID-19, or whether these associations reflect the greater prevalence of medical risk factors in people with psychiatric disorders, has yet to be evaluated.

Methods: We performed an observational multicenter retrospective cohort study to examine the association between psychiatric disorders and mortality among patients hospitalized for laboratory-confirmed COVID-19 at 36 Greater Paris University hospitals.

Results: Of 15,168 adult patients, 857 (5.7%) had an ICD-10 diagnosis of psychiatric disorder. Over a mean follow-up of 14.6 days (SD=17.9), death occurred in 326/857 (38.0%) patients with a diagnosis of psychiatric disorder versus 1,276/14,311 (8.9%) in patients without such a diagnosis (OR=6.27; 95%CI=5.40-7.28; p<0.01). When adjusting for age, sex, hospital, current smoking status, and medications according to compassionate use or as part of a clinical trial, this association remained significant (AOR=3.27; 95%CI=2.78-3.85; p<0.01). However, additional adjustments for obesity and number of medical conditions resulted in a non-significant association (AOR=1.02; 95%CI=0.84-1.23; p=0.86). Exploratory analyses following the same adjustments suggest that a diagnosis of mood disorders was significantly associated with reduced mortality, which might be explained by the use of antidepressants.

Conclusions: These findings suggest that the increased risk of COVID-19-related mortality in individuals with psychiatric disorders hospitalized for COVID-19 might be explained by the greater number of medical conditions and the higher prevalence of obesity in this population, but not by the underlying psychiatric disease.

Keywords: COVID-19; SARS-COV-2; antidepressants; comorbidity; mental disorders; mood disorders; mortality; obesity; psychiatric disorders; risk of death.

This part of the website could either be in French or English, depending on the sources of the actualities.

SIDEBAR_ARCHIVE_TITLE

 01 December 2023
IPNP Seminar Friday December 1st, dr Julie GAVARD Glioblastoma cells walk the line with brain vessels
 28 November 2023
12h30 de la recherche - 28 novembre-Grand Amphi Blanc GHU Sainte-Anne-IPNP
 06 October 2023
IPNP Seminar Friday October 6th, Pr Angeliki LOUVI: Investigating Brain Disease: from Patients to Model Organisms and Beyond
 26 September 2023
12h30 de la recherche - 26 septembre-Grand Amphi Blanc GHU Sainte-Anne-IPNP
 06 September 2023
IPNP Seminar September 6th, Dr Daniel Medina Cano, A stem cell platform to map cell type and stage-specific cis-regulatory variation in mouse embryonic brain development
 01 September 2023
IPNP Seminar Friday September 1st, Pr Annika KELLER, Vascular calcification in the brain
 25 August 2023
Seminar Friday August 25th, Dr Mariana Tasso: Nanobiomaterials: from the beauties of the nanoworld to the quest for real biological applications
 07 July 2023
Friday, July 7th, 2023, noon: Dr Sophie STECULORUM (Host V Tolle) Max Planck Institute, Köln, Germany Sensory regulation of feeding behaviour and metabolism
 02 June 2023
IPNP Seminar June 2nd Noon Pr Christian NOLTE: Myocardial injury in acute ischemic stroke – from heart to brain and back again
 30 May 2023
12h30 de la recherche - 30 mai-Amphi Morel GHU Sainte-Anne-IPNP
 25 April 2023
Hemorrhagic Stroke: Current Research regarding Etiological Diagnosis
 07 April 2023
IPNP Seminar noon friday April 7th 2023: Pr Ype ELGERSMA-Mechanisms underlying Angelman syndrome and the promise of antisense oligonucleotide (ASO) treatment
 17 March 2023
Mitochondria and the social organelle network
 01 March 2023 20 March 2023
Semaine du Cerveau 25ème édition
 01 March 2023 14 March 2023
Conférence inaugurale de la Semaine du Cerveau: Neurosciences et Psychiatrie, un vertueux mariage
 24 February 2023 18 March 2023
NeuroFrance 2023
 02 September 2022
The reciprocal interplay between nutrient sensing and secretory pathways defines cellular homeostasis
 01 July 2022
Cortical wiring by synapsespecific control of local protein synthesis
 20 June 2022
Demars et al. Curr Biol. 2022
 10 June 2022
A "Neurotour de France" - Ep. 2, présentation of IPNP